Shares and Warrants
Directors
As far as is known by the Company, the Directors hold the following financial instruments of Innogenetics as of July 17, 2008:
|
Directors
|
Number of shares
owned or controlled
directly or indirectly
|
% of total shares
outstanding
|
Number of warrants
owned or controlled
|
| Rudi Mariën5 |
5 707 140
|
18.48
|
25 000
|
| Ghislain De Groote5 |
140 320
|
0.45
|
25 000
|
| Gengest BVBA1,5 |
-
|
-
|
25 000
|
| Werner Cautreels5 |
-
|
-
|
25 000
|
| Jos Peeters4,5 |
25 000
|
0.08
|
25 000
|
| Peter Read4,5 |
-
|
-
|
25 000
|
| Pol Bamelis NV2,4,5 |
3 500
|
0.01
|
25 000
|
| Peter Verhaeghe4,5 |
-
|
-
|
20 000
|
| CDW Invest BVBA6,7 |
-
|
-
|
-
|
| Main Holding NV3,4,5 |
98 437
|
0.32
|
20 000
|
1 owned or controlled by Rudi Mariën
2 owned or controlled by Pol Bamelis
3 owned or controlled by Luc Geuten
4 independent Director
5 non-executive Director
6 executive Director
7 owned or controlled by Christiaan De Wilde
Management Committee
As far as is known by the Company, the Members of the Management Committee hold the following financial instruments of Innogenetics as of March 14, 2008:
| Management Committee |
Number of shares
owned or controlled
directly or indirectly
|
% of total shares
outstanding
|
Number of warrants
|
| CDW Invest BVBA1 |
-
|
-
|
75 000
|
| Wolfgang Seidel |
5 000
|
0,02
|
15 000
|
| WVC Consulting BVBA2 |
-
|
-
|
25 000
|
1 owned or controlled by Christiaan De Wilde
2 owned or controlled by Walter Van Cauwenberge
Directors and Officers Liability Insurance
Innogenetics has subscribed to a Directors and Officers liability policy, which covers the liability of Directors and Officers up to €10 million.